Cyanine3 amine
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
110C0 | 1 mg | $125 | in stock | |
210C0 | 5 mg | $260 | in stock | |
410C0 | 25 mg |
$510
|
in stock | |
510C0 | 50 mg |
$895
|
in stock | |
610C0 | 100 mg |
$1490
|
in stock |
Cyanine3 amine is a functionalized cyanine dye containing a free amino group. Cyanine3 is an analog of Cy3®.
Amino group of this reagent can be conjugated with reactive groups such as NHS esters, carboxy groups (after carbodiimide activation), and epoxides.
The amino dye is supplied in salt form, and possesses some aqueous solubility.
Cyanine3 absorption and emission spectra

Customers also purchased with this product
Cyanine5 azide
Cyanine5 azide is a reagent for click chemistry labeling with Cyanine5, a popular fluorescent dye.get free express delivery
FAM amine, 6-isomer
Amine derivative of fluorescein (FAM) fluorophore, pure 6-isomer, for the enzymatic transamination labeling, reactions with electrophilic reagents, and reductive amination.Indocyanine Green (ICG)
Water-soluble and pH-insensitive fluorescent dye widely used in imaging and flow cytometry.General properties
Appearance: | red powder |
Molecular weight: | 627.73 |
CAS number: | 2247688-56-6 |
Molecular formula: | C36H52Cl2N4O |
IUPAC name: | 3H-Indolium, 1-[6-[(6-aminohexyl)amino]-6-oxohexyl]-2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propen-1-yl]-3,3-dimethyl-, chloride, hydrochloride (1:1:1) |
Solubility: | moderate solubility in water, good in polar organic solvents (DMF, DMSO, alcohols) |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
MSDS: | Download |
Product specifications |
Spectral properties
Excitation/absorption maximum, nm: | 555 |
ε, L⋅mol−1⋅cm−1: | 150000 |
Emission maximum, nm: | 570 |
Fluorescence quantum yield: | 0.31 |
CF260: | 0.04 |
CF280: | 0.09 |
Product citations
- Kovshova, T.; Malinovskaya, J.; Kotova, J.; Gorshkova, M.; Vanchugova, L.; Osipova, N.; Melnikov, P.; Vadekhina, V.; Nikitin, A.; Ermolenko, Y.; Gelperina, S. Core–Shell PLGA Nanoparticles: In Vitro Evaluation of System Integrity. Biomolecules, 2024, 14(12), 1601. doi: 10.3390/biom14121601
- Gorshkova, M.; Vanchugova, L.; Osipova, N.; Nikitin, A.; Kotova, J.; Kovalenko, E.; Ermolenko, Y.; Malinovskaya, J.; Kovshova, T.; Gelperina, S. Hybrid DIVEMA/PLGA nanoparticles as the potential drug delivery system. Research Square, 2024, preprint. doi: 10.21203/rs.3.rs-4594368/v1
- Lee, J.-R.; Sim, W.-S.; Park, H.-J.; Park, B.-W.; Joung, Y. K. Targeted Delivery of Apoptotic Cell-Derived Nanovesicles Prevents Cardiac Remodeling and Attenuates Cardiac Function Exacerbation. Advanced Functional Materials, 2023, 33(23), 2210864. doi: 10.1002/adfm.202210864
- Ruan, Z.; Li, S.; Grigoropoulos, A.; Amiri, H.; Hilburg, S. L.; Chen, H.; Jayapurna, I.; Jiang, T.; Gu, Z.; Alexander-Katz, A.; Bustamante, C.; Huang, H.; Xu, T. Population-Based Heteropolymer Design to Mimic Protein Mixtures. Nature, 2023, 615(7951), 251–258. doi: 10.1038/s41586-022-05675-0
Cy® is a trademark of GE Healthcare.
Short link - lumiprobe.com/sh/p/1U
The count of items is incorrect.
